Why did AstraZeneca start trading on Wall Street?

AstraZeneca began trading on the New York Stock Exchange to allow US investors to participate more fully in the company's strong growth.

Will AstraZeneca delist from the London Stock Exchange?

The article states that AstraZeneca is keeping its listings on the London Stock Exchange and in Stockholm, though concerns exist about a future primary listing shift.

What is AstraZeneca's connection to the US market?

AstraZeneca generates almost half of its revenues in the US and has announced plans for significant investment in the country by 2030.

Home / Business and Economy / AstraZeneca's Wall Street Debut Sparks London Fears

AstraZeneca's Wall Street Debut Sparks London Fears

3 Feb

•

Summary

AstraZeneca began trading on the New York Stock Exchange yesterday.
The company retains its London and Stockholm listings.
AstraZeneca aims to boost US investor participation in its growth.

AstraZeneca's Wall Street Debut Sparks London Fears

AstraZeneca shares started trading on the New York Stock Exchange yesterday, initiating an "exciting new period" for the company. This dual listing maintains its presence on the London Stock Exchange, where it is a major entity, and in Stockholm.

The move to list on Wall Street is intended to enable US investors to better participate in the company's robust growth trajectory. AstraZeneca generates nearly half of its revenue within the United States and has ambitious expansion plans there.